-transparent.png){kind=logo}
Glycoproteins have been discovered to be important to platelet function both in normal and pathological states. We have studied membrane glycoprotein patterns in 16 patients with various myeloproliferative disorders. There was an abnormal ratio of glycoprotein I:glycoprotein IV in patients with myeloproliferative disease compared with controls. There was no discernible correlation between glycoprotein pattern and aggregation response or platelet count, but patients with megathrombocytes had higher values for glycoprotein IV than those without megathrombocytes. These experiments suggest that patients with myeloproliferative disorders may have alterations in membrane glycoproteins that could alter platelet function.
R B Bolin, and
T Okumura, and
G A Jamieson
October 1988,
Minerva medica,
R B Bolin, and
T Okumura, and
G A Jamieson
June 1985,
British journal of haematology,
R B Bolin, and
T Okumura, and
G A Jamieson
January 1988,
Progress in clinical and biological research,
R B Bolin, and
T Okumura, and
G A Jamieson
November 1989,
British journal of haematology,
R B Bolin, and
T Okumura, and
G A Jamieson
February 1986,
Prostaglandins, leukotrienes, and medicine,
R B Bolin, and
T Okumura, and
G A Jamieson
April 1988,
Blood,
R B Bolin, and
T Okumura, and
G A Jamieson
June 1979,
Thrombosis and haemostasis,
R B Bolin, and
T Okumura, and
G A Jamieson
June 1994,
The Clinical investigator,
R B Bolin, and
T Okumura, and
G A Jamieson
January 1984,
Cell biochemistry and function,
R B Bolin, and
T Okumura, and
G A Jamieson
September 1978,
Blood,
